Does PEGCETACOPLAN Cause Product dose omission issue? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Product dose omission issue have been filed in association with PEGCETACOPLAN (Empaveli). This represents 4.3% of all adverse event reports for PEGCETACOPLAN.
59
Reports of Product dose omission issue with PEGCETACOPLAN
4.3%
of all PEGCETACOPLAN reports
2
Deaths
26
Hospitalizations
How Dangerous Is Product dose omission issue From PEGCETACOPLAN?
Of the 59 reports, 2 (3.4%) resulted in death, 26 (44.1%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Haemolysis (100)
Off label use (97)
Vitreous floaters (78)
Breakthrough haemolysis (67)
Headache (66)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PEGCETACOPLAN Alternatives Have Lower Product dose omission issue Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB